Diana Buist | |
|---|---|
| Spouse | Ky Haverkamp |
| Academic background | |
| Education | PhD, Epidemiology, 1999, University of Washington MPH, Epidemiology, 1995, Yale University |
| Thesis | Bone mineral density and endogenous hormones and breast cancer risk (1999) |
| Academic work | |
| Institutions | Kaiser Permanente |
Diana S.M. Buist is an American epidemiologist. She is a senior investigator and director of research and strategic partnerships at Kaiser Permanente Washington Research Institute.
Buist was born to the United Kingdom born physician-researchers Sonia and Neil Buist. [1] She earned her PhD in epidemiology from the University of Washington and her MPH in the same subject from Yale University. [2]
Upon earning her PhD,Buist joined the faculty at the Kaiser Permanente Washington Research Institute (formerly known as the Group Health Research Institute) in 1996. [3] She earned her doctorate degree while working full-time as a research associate in Kaiser Permanente women's health group. [4] In 2003,Buist was appointed the leader of the Breast Cancer Surveillance Consortium registry in Washington. [1] While serving in this role,she received $4 million in federal stimulus funding for her research into improving screening for colorectal and cervical cancer. [5] A few years later,Buist was the senior investigator in a study which found that when women quit hormone therapy,their rates of new breast cancer declined. [6]
In 2015,Buist was named the Group Health Research Institute's director of research and strategic partnerships,while continuing her work as a senior investigator pursuing funded scientific research. [3] During the same year,she co-authored a study with Constance D. Lehman and Diana L. Miglioretti which found that computer-aided detection for breast cancer screening was not as effective as previously conceived. [7] In 2019,Buist was the co-author of another research project which determined a self-collected HPV test provided similar results to those of a physician-collected sample. [8]
Buist and her husband Ky Haverkamp have two daughters together,Bryn Buist-Haverkamp &Abby Buist-Haverkamp. [4]
Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast,a change in breast shape,dimpling of the skin,fluid coming from the nipple,a newly inverted nipple,or a red or scaly patch of skin. In those with distant spread of the disease,there may be bone pain,swollen lymph nodes,shortness of breath,or yellow skin.
Kathie-Ann Joseph is a surgeon and researcher at New York University Langone Health where she specializes in breast surgery and oncology surgery. Joseph is also the chief of breast surgery at Bellevue Medical Center,where she was recognized in 2015 as Bellevue's Physician of the Year. Joseph works to reduce disparities in cancer care in order to improve health care for individuals in need. Specifically,Joseph focuses on developing programs that will help African-American women to address their needs in breast cancer prevention and care. She is also studying the effects of a cell surface receptor molecule called RAGE which appears to play a role in tumor growth.
The American Cancer Society Cancer Action Network is a nonprofit,nonpartisan advocacy affiliate of the American Cancer Society. It was founded in September 2001 to directly lobby the goals of the American Cancer Society,which is subject to restrictions on advocacy activities because of its tax classification. ACS CAN works to make cancer a national priority. Specifically,it advocates for better access to care,cancer prevention and early detection programs,cancer research funding,regulation of tobacco by the U.S. Food and Drug Administration,better quality of life for cancer patients,and attempts to raise awareness of and reduce cancer disparities. Members include cancer survivors,caregivers,patients,volunteers,and students,including Colleges Against Cancer.
Dame Valerie Beral AC DBE FRS FRCOG FMedSci was an Australian-born British epidemiologist,academic and a preeminent specialist in breast cancer epidemiology. She was Professor of Epidemiology,a Fellow of Green Templeton College,Oxford and was the Head of the Cancer Epidemiology Unit at the University of Oxford and Cancer Research UK from 1989.
Judith A. Salerno,MD,MS is a physician executive and the President of the New York Academy of Medicine.
Cancer screening aims to detect cancer before symptoms appear. This may involve blood tests,urine tests,DNA tests,other tests,or medical imaging. The benefits of screening in terms of cancer prevention,early detection and subsequent treatment must be weighed against any harms.
Madelon Lubin Finkel is Professor of Population Health Sciences and Inaugural Director Office of Global Health Education (2004-2021) at Weill Cornell Medical College in New York City. She holds a doctorate in epidemiology and health services research from the Graduate School of Arts and Sciences of New York University. Finkel was a visiting professor at the School of Public Health,University of Sydney (Australia) in 2004,and at Chulalongkorn University Faculty of Medicine in Bangkok Thailand in 2016. In 2008,she was named a Fulbright Senior Specialist.
Sumita Prabhakar is an Indian gynecologist,obstetrics and social medico activist. After graduating from Banaras Hindu University,Varanasi,India,she went on to practice at Queen Elizabeth Hospital Malaysia from 1999 to 2001. She returned to India and started practicing at Sitaram Bhartia Institute of Science and Research,Delhi as consultant gynecologist from 2001 to 2002. She serves as the Head of Gynecology at CMI Hospital,Dehradun. She has been organizing free screening and awareness camps for Breast and Cervical cancer since 2014. She served as a president of Federation of Obstetric and Gynaecological Societies of India member body of Dehradun. She has received numerous awards,including the IMA Doctor Achievement Award,Uma Shakti Samman,PNB Hindi Gaurav Samman,Dainik Jagran Medical Excellence Award,Divine Shakti Leadership Award,Youth Icon Award and Medico-Social Activist Award.
Anne Szarewski was a doctor who helped improve how cervical screening samples are tested and was involved in developing the human papillomavirus (HPV) vaccine.
Gretchen L. Gierach is an American epidemiologist and women's health researcher. She is the chief of the Integrative Tumor Epidemiology Branch in the National Cancer Institute.
Nimmi Ramanujam is the Robert W. Carr Professor of Biomedical Engineering,and a faculty member in the Global Health Institute and the Department of Pharmacology &Cell Biology at Duke University. She is the director of the Center of Global Women's Health Technologies (GWHT) and founder of Zenalux Biomedical Inc. and Calla Health. Ramanujam has spent the last two decades developing precision diagnostics and more recently precision therapeutics for breast and cervical cancer,with a focus on addressing global health disparities. She has more than 20 patents and over 150 publications for screening,diagnostic,and surgical applications,and has raised over $30M of funding to pursue these innovations through a variety of funding mechanisms,including NIH R01s and R21s,NIH Bioengineering Partnerships,NCI Academic Industry Partnerships,NIH Small Business grants and USAID funding. As the founding director of the Center for Global Women's Health Technologies at Duke University,she has developed a consortium of over 50+ partners including international academic institutions and hospitals,non-governmental organizations,ministries of health,and commercial partners;this consortium is working to ensure that the technologies developed at the center are adopted by cancer control programs in geographically and economically diverse healthcare settings.
Wendy Rosamund Brewster is a Professor of Obstetrics and Gynaecology and Director of the Center for Women's Health Research at the University of North Carolina at Chapel Hill.
Elzora Mae Kramer Brown was an American breast cancer awareness advocate. Brown worked to improve awareness of breast cancer in the African-American community. She was the first African American woman to serve on the National Cancer Advisory Board.
Ann Hart Partridge is an American medical oncologist. She is the founder and director of the Young and Strong Program for Young Women with Breast Cancer at the Susan F. Smith Center for Women's Cancers at the Dana–Farber Cancer Institute.
Gina Suzanne Ogilvie is a Canadian global and public health physician. She is a Tier 1 Canada Research Chair in Global Control of HPV Related Diseases and Cancer,and Professor at the University of British Columbia in the School of Population and Public Health,Faculty of Medicine.
Emily Banks is an epidemiologist and public health physician,working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University,and a visiting Professor at the University of Oxford.
Diana Lynn Miglioretti is an American biostatistician specializing in the availability and effectiveness of breast cancer screening and in radiation hazards from medical imaging;she has also studied connections between Down syndrome and leukemia. She is Dean's Professor of Public Health Sciences and head of the biostatistics division in the UC Davis School of Medicine. She co-leads the U.S. Breast Cancer Surveillance Consortium.
Katrina A. Blouke Goddard is an American genetic epidemiologist and biostatistician specializing in public health genomics and the translation of genomic applications into clinical practice. Goddard is the director of the division of cancer control and population sciences (DCCPS) at the National Cancer Institute (NCI). She was previously the distinguished investigator and director of translational and applied genomics at the Kaiser Permanente Center for Health Research and a faculty member at Case Western Reserve University.
Karen Canfell is an Australian epidemiologist and cancer researcher.
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.
